Abstract

Macrocycles form an important compound class in medicinal chemistry due to their interesting structural and biological properties. To help design macrocycles, it is important to understand how the conformational preferences are affected upon macrocyclization of a lead compound. To address this, we collected a unique data set of protein–ligand complexes containing “non-macrocyclic” (“linear”) ligands matched with macrocyclic analogs binding to the same protein in a similar pose. Out of the 39 co-crystallized ligands considered, 10 were linear and 29 were macrocyclic. To enable a more general analysis, 128 additional ligands from the publications associated with these protein data bank entries were added to the data set. Using in total 167 collected ligands, we investigated if the conformers in the macrocyclic conformational ensembles were more similar to the bioactive conformation in comparison to the conformers of their linear counterparts. Unexpectedly, in most cases the macrocycle conformational ensemble distributions were not very different from those of the linear compounds. Thus, care should be taken when designing macrocycles with the aim to focus their conformational preference towards the bioactive conformation. We also set out to investigate potential conformational flexibility differences between the two compound classes, computational energy window settings and evaluate a literature metric for approximating the conformational focusing on the bioactive conformation.

Highlights

  • Molecular rigidification restricts the number of conformers a ligand can adopt and is an important tool in medicinal chemistry when developing more potent and selective analogs

  • To facilitate comparisons between linear compounds and macrocy­ clic analogs, structure series were collected from the protein data bank (PDB) where the linear compound and the macrocyclic analog were binding to the same protein, in a similar pose and making similar interactions with the target protein

  • 39 structures consisting of 29 macrocycles and 10 linear compounds were selected from the PDB

Read more

Summary

Introduction

Molecular rigidification restricts the number of conformers a ligand can adopt and is an important tool in medicinal chemistry when developing more potent and selective analogs. Conformational analysis can be used as a tool to evaluate if different linkers enable the adoption of the bioactive conformation.[15,19,20] In the current work, we set out to investigate if synthetic macrocyclic analogs populate conformations closer to the Xray-bound conformation to a higher degree as compared to their nonmacrocyclic counterparts ( called “linear”). We set out to investigate how the macrocyclization affects conformational flexi­ bility and how the purposed linker design metric performs on our collected data set

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call